10 Things You Need to Know About BCRX Stock Forecast in 2025
BioCryst Pharmaceuticals (BCRX) is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel medicines to treat rare diseases. BCRX’s current product pipeline includes five late-stage clinical programs, focusing on inherited metabolic disorders and autoimmune diseases. The company’s most advanced product is Orladeyo (berotralstat), which is approved to treat hereditary angioedema (HAE). … Read more
